Hoverink Biotechnologies, Inc.
801 Century Park E.
24th Floor
Los Angeles, California 90067
info@hoverink.net
866-443-4666
December 29, 2017
VIA EDGAR AND COURIER
United States Securities and Exchange Commission Division of
Corporation Finance
Mail Stop 4720 100 F. Street N.E.
Washington, DC 20549
Re: Hoverink Biotechnologies, Inc .
Application for Withdrawal on Form RW for Registration Statement on
Form 10-12G Filed on Nov 14, 2017
File No: 000-55055
Ladies and Gentlemen:
Hoverink Biotechnologies, Inc. (the “ Company ”), hereby requests, pursuant to Rule 477 of the Securities Act of 1933, as amended (“ Securities Act ”) that the Company’s Registration Statement on Form 10, initially filed with the Securities and Exchange Commission (“ SEC ”) on Nov 14, 2017, as thereafter amended, together with all exhibits and amendments thereto (“ Registration Statement ”), be withdrawn effective immediately. No securities have been issued or sold under the Registration Statement. The Registration Statement has not been declared effective by the SEC. The Company may undertake one or more subsequent private offerings in reliance on Rule 155(c) of the Securities Act. Should you have any questions feel free to contact us at 866-443-4666 ext 113
By: /s/ Debbie Carter
Debbie Carter
Chief Executive Officer
Hoverink Biotechnologies, Inc.
